Bravecto Topical Solution for Dogs

Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. BRAVECTO Topical Solution for Dogs should be applied topically as directed by your veterinarian. Manufacturer Dosage and Administration: Bravecto Topical Solution should be administered topically as a single dose every 12 weeks according to your dog's body weight to provide a minimum dose of 11.4 mg⁄lb (25 mg⁄kg) body weight. Bravecto Topical Solution may be administered every 8 weeks in case of potential exposure toAmblyomma americanum(lone star ticks). Step 1: Immediately before use, open the pouch and remove the tube. Hold the tube at the crimped end with the cap in an upright position (tip up). The cap should be rotated clockwise or counterclockwise one full turn. The cap is designed to stay on the tube for dosing and should not be removed. The tube is open and ready for application when a breaking of the seal is felt. Step 2: The dog should be standing or lying with its back horizontal during application. Part the fur at the administration site. Place the tube tip vertically against the skin between the shoulder blades of the dog. Step 3: Squeeze the tube and gently apply Bravecto in one or more spots starting between the shoulder blades and continuing along the dog's back. Avoid applying an excessive amount of solution in any one spot which may cause some solution to run or drip off of the dog. Bathing or water immersion 3 days after administration will not reduce the effectiveness of Bravecto against fleas andIxodes ricinusticks. Treatment with Bravecto may begin at any time of the year and can continue year–round without interruption.

Missed Doses: If a dose is missed: apply BRAVECTO Topical Solution as soon as you remember, then wait for the full prescribed dosing interval prior to administering the next dose. Do not apply two doses at once. If you have questions about your pet's prescribed dosing schedule (e.g., timing, interval), please consult your veterinarian.

Side Effects: BRAVECTO Topical Solution is generally well tolerated. The most common side effects of this medication are application site reactions (e.g., hair loss, redness, irritation), vomiting, diarrhea, decreased appetite, drowsiness⁄lethargy, salivation, and dermatitis⁄rash. Contact your veterinarian immediately if your pet experiences severe or persistent vomiting, complete loss of appetite, has a seizure or any other neurologic adverse reaction (e.g., tremors, loss of coordination, weakness), or if any signs of a hypersensitivity reaction (e.g., hives, swelling) occur. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian.

Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. For topical use on dogs only– avoid oral ingestion. Not for human use. Keep this and all drugs out of the reach of children. Do not contact or allow children to contact the application site until dry. Keep the product in the original packaging until use to prevent children from getting direct access to the product. Do not eat, drink or smoke while handling the product. Avoid contact with skin and eyes. If contact with eyes occurs, then flush eyes slowly and gently with water. Wash hands and contacted skin thoroughly with soap and water immediately after use of the product. The product is highly flammable. Keep away from heat, sparks, open flame or other sources of ignition. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Bravecto has not been shown to be effective for 12–weeks duration in puppies less than 6 months of age. Bravecto is not effective againstAmblyomma americanum(lone star) ticks beyond 8 weeks after dosing. Do not